je.st
news
Cambrex: 'Either we invest now or turn away API business"
2015-02-10 01:49:38| Biotech - Topix.net
Ongoing demand for large-scale APIs combined with high capacity utilization has driven Cambrex Corporation to allot up to $85m for manufacturing expansion in 2015. The Charles City, Iowa facility manufactures active pharmaceutical ingredients , fine chemicals and pharmaceutical intermediates, and will benefit from a second expansion of $45-50m to in as many years in order to support increased customer demand.
Tags: business
turn
api
invest
Category:Biotechnology and Pharmaceuticals